DEB, R., NARWAT, A., & VERMA, S. (2026). NEBULIZED BUDESONIDE AS ADD-ON TO STANDARD THERAPY IN CHILDREN AGED 5-14 YEARS WITH ACUTE EXACERBATION OF ASTHMA. International Journal of Current Pharmaceutical Research, 18(2), 138–142. https://doi.org/10.22159/ijcpr.2026v18i2.8083